Brief: Evaxion Biotech Reports Fourth Quarter And Full Year 2022 Financial Results And Business Update
27/04/2023 12:36
April 27 (Reuters) - Evaxion Biotech A/S EVAX.O :
* EVAXION BIOTECH FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND BUSINESS UPDATE
* EVAXION BIOTECH A/S Q4 LOSS PER SHARE $0.29
* EVAXION BIOTECH A/S - AS OF DECEMBER 31, CASH AND CASH
EQUIVALENTS $13.2 MILLION, ANTICIPATED TO BE SUFFICIENT TO FUND
OPERATIONS INTO DECEMBER 2023
Source text for Eikon: ID:nGNX3PlRfx
Further company coverage: EVAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma